Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Polish Archives of Internal Medicine|October 29, 2024
Rare transthyretin gene variants (p.Ala45Thr, p.Val91Ala, p.Phe53Cys, p.Ala101Val, p.Glu109Lys, and p.Phe53Leu): diagnostic pitfalls and clinical characteristics of Polish patients with transthyretin cardiac amyloidosisMonika Gawor-Prokopczyk, Marta Lipowska, Grażyna Truszkowska, et al.Biomarkers in Medicine|February 12, 2025
Left ventricular remodeling in atrial fibrillation is associated with elevated NAP-2 and 3-nitrotyrosinePatrycja Mołek-Dziadosz, Joanna Natorska, Paweł T Matusik, et al.Kardiologia Polska|September 28, 2023
Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: A position statement of the Polish Cardiac SocietyJacek Grzybowski, Piotr Podolec, Katarzyna Holcman, et al.Cardiology Journal|February 11, 2022
Effectiveness and safety of PCSK9 inhibitor therapy in patients with familial hypercholesterolemia within a therapeutic program in Poland: Preliminary multicenter dataKrzysztof Chlebus, Barbara Cybulska, Piotr Dobrowolski, et al.Archives of Medical Science : AMS|February 28, 2024
Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levelsBożena Sosnowska, Janina Stepinska, Przemyslaw Mitkowski, et al.Journal of Clinical Medicine|April 3, 2021
Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) RegistryMonika Gawałko, Monika Budnik, Iwona Gorczyca, et al.Journal of Clinical Medicine|October 13, 2021
Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) RegistryAnna Szpotowicz, Iwona Gorczyca, Olga Jelonek, et al.Journal of Clinical Medicine|April 30, 2021
Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry StudyMarcin Wełnicki, Iwona Gorczyca, Wiktor Wójcik, et al.International Journal of Environmental Research and Public Health|October 14, 2022
Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?-Results of the Polish Atrial Fibrillation (POL-AF) RegistryAnna Szyszkowska, Łukasz Kuźma, Beata Wożakowska-Kapłon, et al.Journal of Clinical Medicine|November 10, 2020
Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) RegistryIwona Gorczyca, Olga Jelonek, Beata Uziębło-Życzkowska, et al.Pageof 5